Leadership from Digital Diagnostics – maker of LumineticsCore™ (formerly known as IDx-DR), the first-ever FDA-cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy – signed a memorandum of understanding (MOU) with the Kingdom of Saudi Arabia’s Ministry of Investment during a ceremonial visit with United States of America President Joe Biden. With this MOU in place, the Kingdom and Digital Diagnostics agree to explore potential collaboration around medical services, medical technology, and digital health with a significant economic investment and 1,950 jobs created by 2030.